Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Disease modification in multiple sclerosis: an update.
Measuring the quality of life in patients with multiple sclerosis in clinical practice: a necessary challenge.
The impact of slower walking speed on activities of daily living in patients with multiple sclerosis.
Altered topological organization of white matter structural networks in patients with neuromyelitis optica.
CD44 Deficiency Contributes to Enhanced Experimental Autoimmune Encephalomyelitis: A Role in Immune Cells and Vascular Cells of the Blood-Brain Barrier.
Identity-by-Descent Mapping to Detect Rare Variants Conferring Susceptibility to Multiple Sclerosis.
Developmental maturation of innate immune cell function correlates with susceptibility to central nervous system autoimmunity.
Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1000 Genomes Project.
Place of perineal electrophysiologic testing in multiple sclerosis patients.
Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter.
Detailing intra-lesional venous lumen shrinking in multiple sclerosis investigated by sFLAIR MRI at 7-T.
Expression, purification, crystallization and preliminary X-ray crystallographic analysis of the extracellular olfactomedin domain of gliomedin.
Association of Cerebrospinal Fluid Levels of Lateral Olfactory Tract Usher Substance (LOTUS) With Disease Activity in Multiple Sclerosis.
[Current description of multiple sclerosis].
Myelin loss and axonal ion channel adaptations associated with gray matter neuronal hyperexcitability.
Telemedicine for Monitoring MS Activity and Progression.
Wavelet-Based Scalar-on-Function Finite Mixture Regression Models.
Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases.
Erratum to "Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics"
Distinct serum apolipoprotein A-I levels in neuromyelitis optica and acute transverse myelitis.
RECENT ADVANCES IN MESENCHYMAL STEM CELL IMMUNOMODULATION. THE ROLE OF MICROVESICLES.
Myocarditis and diffuse skeletal muscle oedema: new features of neuromyelitis optica spectrum disorder? A case report.
Neuroimaging of dementia.
Closing the quality gap: revisiting the state of the science (vol. 4: medication adherence interventions: comparative effectiveness).
Cyclosporine in the treatment of a case of fulminant and refractory acute disseminated encephalomyelitis.
Pages
« first
‹ previous
…
392
393
394
395
396
397
398
399
400
…
next ›
last »